PD-L1 antibody drug conjugate for cancer immune-chemo combination therapy

被引：2
|
作者：
Sau, Samaresh [1 ]
Petrovici, Alex [1 ]
Alsaab, Hashem [1 ]
Iyer, Arun K. [1 ]
机构：
[1] Wayne State Univ, Detroit, MI USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-3707
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3707
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Chemo-induced biology of PD-L1 and in vivo combination immune therapy for ovarian cancer
    Grabosch, Shannon
    Zeng, Feitianzhi
    Zhang, Lixin
    Ma, Tianzhou
    Tseng, George
    Edwards, Robert P.
    Vlad, Anda M.
    CANCER RESEARCH, 2016, 76
  • [2] Rationale of combination of anti-PD-1/PD-L1 antibody therapy and radiotherapy for cancer treatment
    Hiro Sato
    Noriyuki Okonogi
    Takashi Nakano
    International Journal of Clinical Oncology, 2020, 25 : 801 - 809
  • [3] Rationale of combination of anti-PD-1/PD-L1 antibody therapy and radiotherapy for cancer treatment
    Sato, Hiro
    Okonogi, Noriyuki
    Nakano, Takashi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (05) : 801 - 809
  • [4] Bisdemethoxycurcumin in combination with α-PD-L1 antibody boosts immune response against bladder cancer
    Shao, Yiqun
    Zhu, Wenjing
    Da, Jun
    Xu, Mingxi
    Wang, Yiwei
    Zhou, Juan
    Wang, Zhong
    ONCOTARGETS AND THERAPY, 2017, 10 : 2675 - 2683
  • [5] Combination therapy with PD-1 or PD-L1 inhibitors for cancer
    Hayashi, Hidetoshi
    Nakagawa, Kazuhiko
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (05) : 818 - 830
  • [6] Combination therapy with PD-1 or PD-L1 inhibitors for cancer
    Hidetoshi Hayashi
    Kazuhiko Nakagawa
    International Journal of Clinical Oncology, 2020, 25 : 818 - 830
  • [7] Combination therapy with L-arginine and α-PD-L1 antibody boosts immune response against osteosarcoma in immunocompetent mice
    He, Xiaojun
    Lin, Haiqing
    Yuan, Li
    Li, Binghao
    CANCER BIOLOGY & THERAPY, 2017, 18 (02) : 94 - 100
  • [8] PD-1/PD-L1 Monoclonal Antibody Development for Canine Cancer Therapy
    Choi, Jin Wook
    Withers, Sita S.
    Sciammas, Roger
    Rebhun, Robert B.
    McSorley, Stephen J.
    JOURNAL OF IMMUNOLOGY, 2018, 200 (01):
  • [9] PD-1/PD-L1 immune checkpoint: Potential target for cancer therapy
    Dermani, Fatemeh K.
    Samadi, Pouria
    Rahmani, Golebagh
    Kohlan, Alisa K.
    Najafi, Rezvan
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (02) : 1313 - 1325
  • [10] PDL-1 Antibody Drug Conjugate for Selective Chemo-Guided Immune Modulation of Cancer
    Sau, Samaresh
    Petrovici, Alex
    Alsaab, Hashem O.
    Bhise, Ketki
    Iyer, Arun K.
    CANCERS, 2019, 11 (02):
12345